Cargando…
PLGA Nanoparticles for the Intraperitoneal Administration of CBD in the Treatment of Ovarian Cancer: In Vitro and In Ovo Assessment
The intraperitoneal administration of chemotherapeutics has emerged as a potential route in ovarian cancer treatment. Nanoparticles as carriers for these agents could be interesting by increasing the retention of chemotherapeutics within the peritoneal cavity. Moreover, nanoparticles could be intern...
Autores principales: | Fraguas-Sánchez, Ana I., Torres-Suárez, Ana I., Cohen, Marie, Delie, Florence, Bastida-Ruiz, Daniel, Yart, Lucile, Martin-Sabroso, Cristina, Fernández-Carballido, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285054/ https://www.ncbi.nlm.nih.gov/pubmed/32397428 http://dx.doi.org/10.3390/pharmaceutics12050439 |
Ejemplares similares
-
Active Targeted Nanoformulations via Folate Receptors: State of the Art and Future Perspectives
por: Martín-Sabroso, Cristina, et al.
Publicado: (2021) -
Linking unfolded protein response to ovarian cancer cell fusion
por: Yart, Lucile, et al.
Publicado: (2022) -
Antibody-Antineoplastic Conjugates in Gynecological Malignancies: Current Status and Future Perspectives
por: Martín-Sabroso, Cristina, et al.
Publicado: (2021) -
Functionalization of Morin-Loaded PLGA Nanoparticles with Phenylalanine Dipeptide Targeting the Brain
por: Alonso, Mario, et al.
Publicado: (2022) -
Limitations and Challenges in the Stability of Cysteamine Eye Drop Compounded Formulations
por: Martín-Sabroso, Cristina, et al.
Publicado: (2021)